New survey suggests priobiotics could be the key to encouraging more patients to complete a course of antibiotics
Better education is key to reduce ‘frightening’ levels of drug wastage. A study of UK doctors carried out by the PCSG (Primary... Read More
Journal Watch
Below are some of the articles, which, over the past six months, have caught my eye either due to their general gastroenterological... Read More
Inconsistent care for hereditary colorectal cancer patients
A new survey by the British Society of Gastroenterology (BSG) Cancer Group has revealed great variation in the management of patients at increased risk... Read More
Only 30 days until UEG Week 2013 in Berlin
Group hypnotherapy provides long-term benefits to patients with irritable bowel syndrome: meet the expert who conducted the study Only 30 days until... Read More
New report shows improvement for patients with IBD following biological therapy
Over half of patients saw an improvement after being treated with biological therapies for inflammatory bowel disease (IBD). Data from the first... Read More
Medicine meets art in a not so material world…..
One of the PCSG Digest’s distinguished cover artists, Dr Aruna Mene, Consultant Histopathologist at the Royal Blackburn Hospital, has a solo exhibition... Read More
Nice quality standard
The Acute upper gastrointestinal bleeding quality standard has now been published. You can view the quality standard by following this link: Click... Read More
Scientists discover gene mutations causing pancreatitis
Hyderabad: Scientists from the Centre for Cellular and Molecular Biology (CCMB) and the Asian Institute of Gastroenterology(AIG) here, in collaboration with a group... Read More
No effect on Crohn’s disease relapse from probiotic yeast therapy
Patients with Crohn’s disease in remission did not experience fewer episodes of relapse when treated with probiotic yeast Saccharomyces boulardii compared with... Read More
Probiotics do not prevent relapse in Crohn’s disease patients
Despite previous data showing beneficial effects, the probiotic Saccharomuces boulardii (S. boulardii) does not prevent clinical relapse in patients with Crohn’s disease,... Read More